Delivering API-In-Capsule for Potent, Low-Flow Compounds

A client approached us requesting supplies for a First-in-Human (FIH) study. Initial requirements were for less than 1000 capsules of two different dosage strengths. No formulation studies were to take place, as the client wanted to save time and API for reasons outlined previously. A decision was taken to manufacture these supplies manually using an analytical balance.

The client subsequently contacted us about a re-supply of 25mg and 100mg capsules in quantities of greater than 10,000 and 5,500, respectfully. It was quickly decided that an automated process was the best solution for manufacture of re-supplies.

Download our latest case study to find out more.